 |
|
|
| |
Baseline nucleotide polymorphisms within HBV target site in chronic hepatitis B subjects do not impact HBsAg reductions mediated by RNA interference therapeutic Imdusiran (AB-729)
|
| |
| |
AASLD 2023 nov 10-14
https://www.aasld.org/the-liver-meeting
Christine L Espiritu, Holly Micolochick Steuer, Andrzej Ardzinski, Varun Sharma, Timothy Eley, Karen D Sims, Amy CH Lee, Rene Rijnbrand, Andrea Cuconati, Nagraj Mani, Angela M Lam, Michael J Sofia, and Emily P Thi Arbutus Biopharma Inc., Warminster PA, USA
|
| |
|
|
|
|
|
